Novartis Ag

Katharine Louise Turner

David Andrew Sandham

Simon James Watson

Kamlesh Jagdis Bala

Brian Cox

Lyndon Nigel Brown

Catherine LeBlanc

Catherine Leblanc

Ian Bruce

Robin Alec Fairhurst

Roger John Taylor

Bernard Cuenoud

David Beattie

Neil John Press

Reamonn Madden

There are provided according to the invention compounds of formula (I) in free or salt form, wherein R, R, R, R, R, R, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.

Pyrrolopyridine derivatives and their use as CRTH2 antagonists

There are provided according to the invention compounds of formula (I), in free or salt form, wherein R, R, R, R, R, R, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals. 

Organic compounds

Compounds of formula I in free or salt form, wherein &#x2014;C&#x2014;Y&#x2014;, Rand Rare G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the &#x3b2;-adrenoreceptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

Quinoline-2-one derivatives for the treatment of airways diseases

There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R 4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.

Pyrrolopyridine derivatives and their use as Crth2 antagonists

Growing community of inventors

Horsham, United Kingdom

Katharine Louise Turner